JP2003508761A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508761A5
JP2003508761A5 JP2001520897A JP2001520897A JP2003508761A5 JP 2003508761 A5 JP2003508761 A5 JP 2003508761A5 JP 2001520897 A JP2001520897 A JP 2001520897A JP 2001520897 A JP2001520897 A JP 2001520897A JP 2003508761 A5 JP2003508761 A5 JP 2003508761A5
Authority
JP
Japan
Prior art keywords
protein
molecule
encoding
encoded
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001520897A
Other languages
English (en)
Japanese (ja)
Other versions
JP4803933B2 (ja
JP2003508761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/023414 external-priority patent/WO2001016352A1/en
Publication of JP2003508761A publication Critical patent/JP2003508761A/ja
Publication of JP2003508761A5 publication Critical patent/JP2003508761A5/ja
Application granted granted Critical
Publication of JP4803933B2 publication Critical patent/JP4803933B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001520897A 1999-08-27 2000-08-25 インビトロ翻訳タンパク質の符号化方法および選別方法 Expired - Lifetime JP4803933B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15126199P 1999-08-27 1999-08-27
US60/151,261 1999-08-27
PCT/US2000/023414 WO2001016352A1 (en) 1999-08-27 2000-08-25 Methods for encoding and sorting in vitro translated proteins

Publications (3)

Publication Number Publication Date
JP2003508761A JP2003508761A (ja) 2003-03-04
JP2003508761A5 true JP2003508761A5 (cg-RX-API-DMAC7.html) 2010-06-24
JP4803933B2 JP4803933B2 (ja) 2011-10-26

Family

ID=22537976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001520897A Expired - Lifetime JP4803933B2 (ja) 1999-08-27 2000-08-25 インビトロ翻訳タンパク質の符号化方法および選別方法

Country Status (6)

Country Link
US (2) US6436665B1 (cg-RX-API-DMAC7.html)
EP (1) EP1212452B1 (cg-RX-API-DMAC7.html)
JP (1) JP4803933B2 (cg-RX-API-DMAC7.html)
AU (1) AU779653B2 (cg-RX-API-DMAC7.html)
CA (1) CA2382545C (cg-RX-API-DMAC7.html)
WO (1) WO2001016352A1 (cg-RX-API-DMAC7.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1068356B8 (en) * 1998-04-03 2007-01-03 Adnexus Therapeutics, Inc. Addressable protein arrays
DE19923966C2 (de) * 1999-05-25 2003-04-24 Phylos Inc Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung
CA2377468C (en) * 1999-07-27 2010-04-20 Phylos, Inc. Peptide acceptor ligation methods
CA2382545C (en) * 1999-08-27 2013-08-13 Phylos, Inc. Methods for encoding and sorting in vitro translated proteins
DE19959857C1 (de) * 1999-12-10 2001-06-28 Aventis Res & Tech Gmbh & Co Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung
PT1423400E (pt) * 2001-03-19 2006-12-29 Harvard College Evolução de nova função molecular
EP1419274A4 (en) * 2001-07-31 2006-02-08 Phylos Inc MODULAR CONSTRUCTION OF NUCLEIC ACID PROTEIN FUSION MULTIMERS
US7125669B2 (en) * 2001-11-27 2006-10-24 Compound Therapeutics, Inc. Solid-phase immobilization of proteins and peptides
WO2004016767A2 (en) 2002-08-19 2004-02-26 The President And Fellows Of Harvard College Evolving new molecular function
WO2004024084A2 (en) * 2002-09-12 2004-03-25 Massachusetts Institute Of Technology Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling
US20050019806A1 (en) * 2003-06-30 2005-01-27 Horvitz H. Robert Nucleic acids and polypeptides required for cell survival in the absence of Rb
WO2005074417A2 (en) * 2003-09-03 2005-08-18 Salk Institute For Biological Studies Multiple antigen detection assays and reagents
US8299210B2 (en) * 2003-11-20 2012-10-30 Sanofi Pasteur Methods for purifying pertussis toxin and peptides useful therefor
AU2005220746A1 (en) 2004-03-05 2005-09-22 Medical College Of Ohio Methods and compositions for assessing nucleic acids and alleles
WO2005106036A2 (en) 2004-04-12 2005-11-10 Medical College Of Ohio Methods and compositions for assaying analytes
US20050260652A1 (en) * 2004-04-15 2005-11-24 The General Hospital Corporation Compositions and methods that modulate RNA interference
US7635563B2 (en) * 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
EP1951890A4 (en) 2005-11-16 2009-06-24 Ambrx Inc PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
US8420081B2 (en) 2007-11-30 2013-04-16 Abbvie, Inc. Antibody formulations and methods of making same
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
EP3062106B1 (en) 2008-04-16 2020-11-11 The Johns Hopkins University Method for determining androgen receptor variants in prostate cancer
KR20110036638A (ko) 2008-07-25 2011-04-07 리차드 더블유. 와그너 단백질 스크리닝 방법
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
US20100158822A1 (en) * 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
SG173627A1 (en) 2009-02-13 2011-09-29 Chem Inc X Methods of creating and screening dna-encoded libraries
CN102596155A (zh) * 2009-03-30 2012-07-18 庄臣消费者有限公司 用于递送美容试剂的基于肽的系统
WO2010114638A1 (en) 2009-03-30 2010-10-07 E. I. Du Pont De Nemours And Company Peptide-based tooth whitening reagents
US9989533B2 (en) 2009-05-28 2018-06-05 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Anti-TNF induced apoptosis (ATIA) diagnostic markers and therapies
MX2012009318A (es) 2010-02-10 2012-09-07 Novartis Ag Metodos y compuestos para el crecimiento muscular.
EP2655413B1 (en) * 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
DE102010056289A1 (de) 2010-12-24 2012-06-28 Geneart Ag Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
WO2012112685A2 (en) 2011-02-15 2012-08-23 The Johns Hopkins University Compositions and methods for diagnosing ovarian cancer
EP3798236B1 (en) 2011-03-15 2022-08-10 X-Body, Inc. Antibody screening methods
SG10201900183VA (en) 2011-04-28 2019-05-30 Univ Leland Stanford Junior Identification of polynucleotides associated with a sample
DK2748357T3 (en) 2011-09-07 2018-07-16 X Chem Inc Methods for labeling DNA-encoded libraries
CN107353342B (zh) 2011-12-05 2021-08-10 X 博迪生物科学公司 PDGF受体β结合多肽
KR102146721B1 (ko) 2012-07-13 2020-08-21 엑스-켐, 인크. 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리
US10487363B2 (en) 2013-01-23 2019-11-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for detecting neoplasia
CA2904170A1 (en) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US20140327460A1 (en) * 2013-05-03 2014-11-06 Second Sight Medical Products, Inc. Test Apparatus and Method for Determining Long Term Reliability of an Implantable Device
CA3210220A1 (en) 2013-05-10 2014-11-13 Johns Hopkins University Compositions for ovarian cancer assessment having improved specificity
US10370651B2 (en) 2013-06-28 2019-08-06 X-Body, Inc. Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
AU2014321251B2 (en) 2013-09-23 2020-04-16 X-Body, Inc. Methods and compositions for generation of binding agents against cell surface antigens
WO2015179404A1 (en) 2014-05-19 2015-11-26 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
WO2016033114A1 (en) 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
JP6478392B2 (ja) * 2014-12-26 2019-03-06 国立研究開発法人産業技術総合研究所 核酸リンカー
EP3386594B1 (en) 2015-12-11 2023-05-03 The General Hospital Corporation Combination of a platelet-derived growth factor receptor alpha inhibitor and a histone lysine demethylase inhibitor for treating drug-tolerant glioblastoma
US12130290B2 (en) 2016-11-29 2024-10-29 Trustees Of Tufts College Compositions and methods for diagnosing breast cancer
EP3669004A1 (en) 2017-08-16 2020-06-24 Medimmune, LLC Compositions and methods for treatment of atopic dermatitis and treatment selection
US11988663B2 (en) 2018-12-18 2024-05-21 The University Of Memphis Research Foundation Compositions and methods for the detection and molecular profiling of membrane bound vesicles
WO2022197933A1 (en) 2021-03-18 2022-09-22 The Broad Institute, Inc. Compositions and methods for characterizing lymphoma and related conditions
WO2023122723A1 (en) 2021-12-23 2023-06-29 The Broad Institute, Inc. Panels and methods for diagnosing and treating lung cancer
WO2025106804A1 (en) 2023-11-16 2025-05-22 Massachusetts Institute Of Technology Compositions and methods for characterizing hepatocyte stress
WO2025217069A1 (en) 2024-04-08 2025-10-16 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for treating cardiotoxicity
WO2026096383A1 (en) 2024-10-28 2026-05-07 The Broad Institute, Inc. Compositions and methods for inducing phagocytosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639603A (en) 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
JP2547149B2 (ja) * 1992-03-05 1996-10-23 三洋化成工業株式会社 免疫測定法及び免疫測定用試薬キット
GB2284208A (en) * 1993-11-25 1995-05-31 Pna Diagnostics As Nucleic acid analogues with a chelating functionality for metal ions
US5695934A (en) * 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
IL131016A (en) * 1997-01-21 2004-12-15 Gen Hospital Corp Selection of proteins using RNA-protein blends
US6261804B1 (en) * 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
JPH10253632A (ja) * 1997-03-10 1998-09-25 Nissui Pharm Co Ltd 分析方法、キット及び装置
EP1068356B8 (en) * 1998-04-03 2007-01-03 Adnexus Therapeutics, Inc. Addressable protein arrays
EP1073730A1 (en) * 1998-04-17 2001-02-07 Whitehead For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
DK1105360T3 (da) * 1998-08-17 2009-11-02 Bristol Myers Squibb Co Identifikation af forbindelse-protein-interaktioner ved anvendelse af biblioteker af protein-nukleinsyrefusionsmolekyler
CA2382545C (en) * 1999-08-27 2013-08-13 Phylos, Inc. Methods for encoding and sorting in vitro translated proteins

Similar Documents

Publication Publication Date Title
JP4803933B2 (ja) インビトロ翻訳タンパク質の符号化方法および選別方法
RU2238326C2 (ru) Способ продуцирования библиотеки белков (варианты), способ отбора нужного белка и нуклеиновой кислоты
US8207093B2 (en) Selection of proteins using RNA-protein fusions
CA2350417C (en) Dna-protein fusions and uses thereof
US6214553B1 (en) Libraries of protein encoding RNA-protein fusions
EP1816192B1 (en) LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE
EP3150750B1 (en) Peptide constructs and assay systems
US7125669B2 (en) Solid-phase immobilization of proteins and peptides
WO2009077173A2 (en) Dna-encoded chemical libraries
JPH04504409A (ja) 免疫親和技術を用いた連続ペプチド及びオリゴヌクレオチド合成
JPH10179197A (ja) 隣接してアニーリングしたプローブの三重らせん形成を用いる核酸の同定方法
JP5733784B2 (ja) ｃＤＮＡ／ｍＲＮＡ−タンパク質連結体の効率的合成法
WO2003062417A1 (fr) Produit de ligation arn-adn, et utilisation correspondante
US20040197779A1 (en) Methods for analyzing mixtures of proteins
JP2004097213A (ja) 核酸および／またはタンパク質の選択方法
JPWO2005001086A1 (ja) 固定化ｍＲＮＡ−ピューロマイシン連結体及びその用途
WO2021182587A1 (ja) 光架橋塩基を活用した、新規ペプチドアプタマー探索用標的モジュール、新規ペプチドアプタマー探索用リンカー及びそれらを用いる新規ペプチドアプタマーの探索方法
JP2003070483A (ja) 核酸の連結方法